Anders Axelsson, Bjärred (SE); Arne Kristensen, Helsingborg (SE); and Henri Hansson, Helsingborg (SE)
Assigned to Modoral Brands Inc., Winston-Salem, NC (US)
Filed by Modoral Brands Inc., Winston-Salem, NC (US)
Filed on Jun. 19, 2024, as Appl. No. 18/747,882.
Application 18/747,882 is a continuation of application No. 17/947,974, filed on Sep. 19, 2022.
Application 17/947,974 is a continuation of application No. 17/458,997, filed on Aug. 27, 2021, granted, now 11,547,660, issued on Jan. 10, 2023.
Application 17/458,997 is a continuation of application No. 16/194,969, filed on Nov. 19, 2018, granted, now 11,129,792, issued on Sep. 28, 2021.
Application 16/194,969 is a continuation of application No. 13/690,531, filed on Nov. 30, 2012, granted, now 10,219,999, issued on Mar. 5, 2019.
Application 13/690,531 is a continuation of application No. 12/225,262, granted, now 9,402,809, issued on Aug. 2, 2016, previously published as PCT/EP2007/002343, filed on Mar. 16, 2007.
Claims priority of provisional application 60/782,903, filed on Mar. 16, 2006.
Claims priority of provisional application 60/782,977, filed on Mar. 16, 2006.
Claims priority of application No. 2006 00376 (DK), filed on Mar. 15, 2006; and application No. 2006 00375 (DK), filed on Mar. 16, 2006.
1. A composition for buccal administration, the composition comprising:
carrier particles;
a sugar alcohol; and
nicotine;
wherein the carrier particles and the nicotine together comprise about 45% or greater by weight of the composition, based on the total weight of the composition; and
wherein the composition is enclosed within a semi-permeable membrane.
